IBRX
ImmunityBio, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$5.88
$-0.45
(-7.11%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $5.79B | EPS (ttm) | $-0.41 | Current Price | $5.88 |
| Enterprise Value | $6.84B | Forward EPS | $-0.26 | Previous Close | $6.33 |
| P/E Ratio | - | ROA | -36.89% | 52W High | $8.28 |
| Forward P/E | -22.91 | ROE | - | 52W Low | $1.83 |
| PEG Ratio | - | Gross Margin | 99.55% | 50 Day Avg | $3.23 |
| P/S Ratio | 70.15 | Operating Margin | -173.51% | 200 Day Avg | $2.72 |
| P/B Ratio | -11.05 | Profit Margin | - | Volume | 21.18M |
| EV/EBITDA | -27.92 | Current Ratio | 5.77 | Avg Volume | 25.60M |
| EV/Sales | 82.84 | Quick Ratio | 5.10 | Beta | 0.02 |
| Employees | 673.00 | Debt/Equity | - | Shares Outstanding | 984.97M |
| Sector | Healthcare | Total Debt | $861.29M | Float Shares | 336.49M |
| Industry | Biotechnology | Total Cash | $257.81M | Short Float | 38.38% |
| Optionable | Yes | Cash/Share | $0.26 | Short Ratio | 6.84 |
| Dividend Yield | - | Book Value/Share | $-0.53 | % Held by Insiders | 66.41% |
| Target Price | $11.80 | Revenue (TTM) | $82.56M | % Held by Institutions | 15.47% |